The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Cardiovascular Death and Left Ventricular Remodeling Two Years After Myocardial Infarction: Baseline Predictors and Impact of Long-term Use of Captopril: Information From the Survival and Ventricular Enlargement (SAVE) Trial
Abstract
Background We quantified cardiovascular death and/or left ventricular (LV) dilatation in patients from the SAVE trial to determine whether dilatation continued beyond 1 year, whether ACE inhibitor therapy attenuated late LV dilatation, and whether any baseline descriptors predicted late dilatation. Methods and Results Two-dimensional echocardiograms were obtained in 512 patients at 11±3 days and 1 and 2 years postinfarction to assess LV size, percentage of the LV that was akinetic/dyskinetic (%AD), and LV shape index. LV function was assessed by radionuclide ejection fraction. Two hundred sixty-three patients (51.4%) sustained cardiovascular death and/or LV diastolic dilatation; 279 (54.5%) had cardiovascular death and/or systolic dilatation. In 373 patients with serial echocardiograms, LV end-diastolic and end-systolic sizes increased progressively from baseline to 2 years (both P <.01). More patients with LV dilatation had a decrease in ejection fraction: 24.8% versus 6.8% ( P <.001) (diastole) and 25.7% versus 5.3% ( P <.001) (systole). Captopril attenuated diastolic LV dilatation at 2 years ( P =.048), but this effect was carried over from the first year of therapy because changes in LV size with captopril beyond 1 year were similar to those with placebo. Predictors of cardiovascular death and/or dilatation were age ( P =.023), prior infarction ( P <.001), lower ejection fraction ( P <.001), angina ( P =.007), heart failure ( P =.002), LV size ( P <.001), and infarct size (%AD) ( P <.001). Conclusions Cardiovascular death and/or LV dilatation occurred in >50% of patients by 2 years. LV dilatation is progressive, associated with chamber distortion and deteriorating function that is unaffected by captopril beyond 1 year.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Self-citation(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Pfeffer, M. A., & Braunwald, E. (1990) · Circulation · doi:10.1161/01.cir.81.4.1161 · Cited by 2,877
Self-citationWhite, H. D., Norris, R. M., Brown, M. A., Brandt, P. W., Whitlock, R. M., & Wild, C. J. (1987) · Circulation · doi:10.1161/01.cir.76.1.44 · Cited by 2,363
(1993) · New England Journal of Medicine · doi:10.1056/nejm199311253292204 · Cited by 1,866
Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · The Lancet · Cited by 1,860
GRUPPOITALIANOPERLOSTUDIODELL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90232-1 · Cited by 1,118
Collins, R. T., Peto, R., Flather, M. D., Parish, S., Sleight, P., Conway, M. A., Pipilis, A., Baigent, C., Barnett, D., Boissel, J., et al. (1995) · Ghent University Academic Bibliography (Ghent University) · Cited by 1,115
Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,103
Self-citation
Cited by
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Bellenger, N. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2011 · Cited by 1,040
Solomon, S. D., Anavekar, N., Skali, H., McMurray, J. J. V., Swedberg, K., Yusuf, S., Granger, C. B., Michelson, E. L., Wang, D., Pocock, S., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.561423 · Cited by 873
Self-citationAldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
Morishima, I., Sone, T., Okumura, K., Tsuboi, H., Kondo, J., Mukawa, H., Matsui, H., Toki, Y., Ito, T., & Hayakawa, T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00865-2 · Cited by 577
Metadata
- Authors
- Sutton, M. S. J., Pfeffer, M. A., Moye, L., Plappert, T., Rouleau, J. L., Lamas, G., Rouleau, J., Parker, J. O., Arnold, M. O., Sussex, B., & Braunwald, E.
- Venue
- Circulation
- Published
- 1997-11-18
- Volume
- 96
- Issue
- 10
- Pages
- 3294-3299
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2047605126
- Cited by
- 484
- References
- 32
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular Death and Left Ventricular Remodeling Two Years After Myocardial Infarction: Baseline Predictors and Impact of Long-term Use of Captopril: Information From the Survival and Ventricular Enlargement (SAVE) Trial. https://app.cochat.ai/papers/10.1161/01.cir.96.10.3294
- The paper
- Sutton, M. S. J., Pfeffer, M. A., Moye, L., Plappert, T., Rouleau, J. L., Lamas, G., Rouleau, J., Parker, J. O., Arnold, M. O., Sussex, B., & Braunwald, E. (1997). Cardiovascular Death and Left Ventricular Remodeling Two Years After Myocardial Infarction: Baseline Predictors and Impact of Long-term Use of Captopril: Information From the Survival and Ventricular Enlargement (SAVE) Trial. Circulation. https://doi.org/10.1161/01.cir.96.10.3294
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
